SRINAGAR: Dr Hameed Raina, a gastroenterologist and therapeutic endoscopist from Hussipora, Chadoora in Budgam district, has ...

The global bronchial biopsy devices market was valued at approximately USD 604.73 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7.2% during the forecast period ...

This recommendation is unchanged from the 2017 ASCO Sentinel Lymph Node Biopsy for Patients with Early-Stage Breast Cancer 3 and the 2021 joint Ontario Health (OH; Cancer Care Ontario)-ASCO Management ...

The global endoscopy devices market size is calculated at USD 63.44 billion in 2025 and is expected to reach around USD 88.55 billion by 2034, growing at a CA ...

Flexible nasal endoscopy, particularly when integrated with artificial intelligence and optical biopsy methods, has shown promise in the early detection of laryngeal cancer. Yet, there is little ...

Conclusion Liquid biopsy holds immense promise as a minimally invasive tool for early cancer detection and monitoring, offering significant advantages over traditional tissue biopsies.

Esophagogastroduodenoscopy and colonoscopy play important roles in diagnosing gastrointestinal bleeding; however, they may sometimes fail to identify the source of the bleeding during the initial ...

Worldwide, a limiting factor in the use of endoscopy is the lack of trained gastroenterologists. Research has shown that nonphysician clinicians (such as nurses) with specific training can ...

Gastric cancer detection rates may improve, though at an inconsistent rate, with computer-aided detection in EGD.

Endoscopic ultrasound guided fine needle biopsy has high diagnostic value for pancreatic diseases and is widely used in the diagnosis of pancreatic diseases. Some emerging ultrasound endoscopic ...

Very little research exists regarding the risk associated with a brain biopsy scar. The primary risks are related to the surgical procedure itself, which may trigger seizures or cause neurological ...

Omitting biopsy in patients with a negative prostate MRI more than halves the diagnoses of clinically insignificant prostate cancer.